Facilities

People are at the heart of our achievements.  Indeed, it is the exceptional knowledge and experience of our research staff that underpins our ongoing R&D programmes.  More than 200 experienced researchers are employed in our R & D facilities.  The combined experience of the R&D staff represents over 900 years in the field of medical diagnostics.
 
Most of our research and development activities are currently carried out in our facilities in Jena (Clondiag) Germany; Stirling (Stirling Medical Innovations) UK; San Diego (Biosite) and Hayward (Cholestech), California; Scarborough (Binax), Maine; Bedford, UK; Cambridge (Cambridge Medical Innovations) UK; Brisbane, Australia and Orgenics, Israel. Clondiag in Jena Germany is focused on developing novel point of care testing platforms, while Stirling Medical Innovations and Biosite (San Diego) are major R&D facilities focused on the development of new professional diagnostic tests and monitoring devices primarily related to cardiovascular disease.

To develop and manufacture our range of medical diagnostic products requires a broad knowledge base. That is why our expertise covers so many fields, from immunochemistry to biochemistry, synthetic chemistry to electrochemistry, microbiology to mechanical and electronic engineering, statistics to endocrinology.  The level and scope of the skills represented in our R&D group are a significant factor of our continued success.

The Inverness Medical innovations research and development team possesses an expertise that stands at the forefront of rapid assay technology, and has created numerous patents that have become benchmarks across the entire diagnostics industry. This has helped us to build a reputation for answering complex scientific questions with solutions that are effective and user-friendly. With our state-of-the art research & development laboratories we continue to anticipate consumer and clinical needs. By doing so, we expect to develop exciting and innovative products over the coming years and beyond.